We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+6.21%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$67.7B
AUM Growth
+$7.66B
Cap. Flow
+$4.1B
Cap. Flow %
6.06%
Top 10 Hldgs %
19.84%
Holding
4,573
New
154
Increased
1,566
Reduced
1,807
Closed
132

Sector Composition

Rank Sector Weight
1 Technology 9.69%
2 Financials 7.23%
3 Communication Services 6.56%
4 Healthcare 6.15%
5 Consumer Discretionary 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFYT
3226
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$24.9K ﹤0.01%
404
REVG
3227
DELISTED
REV Group
REVG
$24.9K ﹤0.01%
1,586
+21
+1% +$343
BCRX icon
3228
BioCryst Pharmaceuticals
BCRX
$2.44B
$24.9K ﹤0.01%
3,257
HSKA
3229
DELISTED
Heska Corp
HSKA
$24.8K ﹤0.01%
219
-519
-70% -$54.5K
VKTX icon
3230
Viking Therapeutics
VKTX
$3.86B
$24.8K ﹤0.01%
1,424
CTBI icon
3231
Community Trust Bancorp
CTBI
$1.44B
$24.8K ﹤0.01%
535
-493
-48% -$24.3K
VRA icon
3232
Vera Bradley
VRA
$94.4M
$24.6K ﹤0.01%
1,615
-438
-21% -$6.39K
TDW icon
3233
Tidewater
TDW
$4.74B
$24.4K ﹤0.01%
783
UTL icon
3234
Unitil
UTL
$992M
$24.4K ﹤0.01%
479
-490
-51% -$25K
LDL
3235
DELISTED
Lydall, Inc.
LDL
$24.3K ﹤0.01%
564
UVSP icon
3236
Univest Financial
UVSP
$1.19B
$24.2K ﹤0.01%
916
-1,038
-53% -$28.9K
USCR
3237
DELISTED
U S Concrete, Inc.
USCR
$24.2K ﹤0.01%
527
EZPW icon
3238
Ezcorp Inc
EZPW
$1.81B
$24.1K ﹤0.01%
2,252
-3,130
-58% -$35.6K
UTMD icon
3239
Utah Medical Products
UTMD
$231M
$24K ﹤0.01%
255
NVAX icon
3240
Novavax
NVAX
$1.31B
$23.9K ﹤0.01%
635
-196
-24% -$5.52K
SUP
3241
DELISTED
Superior Industries International
SUP
$23.7K ﹤0.01%
1,388
-591
-30% -$11.4K
CARO
3242
DELISTED
Carolina Financial Corp.
CARO
$23.6K ﹤0.01%
625
-814
-57% -$33.7K
HTGC icon
3243
Hercules Capital
HTGC
$3.13B
$23.5K ﹤0.01%
1,788
+85
+5% +$1.13K
MYE icon
3244
Myers Industries
MYE
$1.23B
$23.5K ﹤0.01%
1,009
-806
-44% -$17.3K
CHRS icon
3245
Coherus Oncology
CHRS
$181M
$23.4K ﹤0.01%
1,421
SGYP
3246
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$23.4K ﹤0.01%
13,778
-1,691
-11% -$3.03K
ADAM
3247
Adamas Trust
ADAM
$907M
$23.3K ﹤0.01%
959
-1,329
-58% -$33.2K
KDNY
3248
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$23.3K ﹤0.01%
635
+56
+10% +$1.8K
NVEE
3249
DELISTED
NV5 Global
NVEE
$23.3K ﹤0.01%
1,076
-184
-15% -$3.79K
FOSL icon
3250
PUT
Fossil Group
FOSL
$326M
$23.3K ﹤0.01%
10

Similar funds

BNP Paribas Financial Markets's Q3 2018 Portfolio in Review

As of Q3 2018, BNP Paribas Financial Markets held 4,573 positions worth $67.7B, up 13% from $60.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

BNP Paribas Financial Markets deployed $4.1B of net new capital in Q3 2018, opening 154 new positions and adding to 1,566 existing holdings. Its largest new stake was iShares Russell 2000 Value ETF: 504,000 shares worth $67M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 7.7% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $261M trimmed.

  • BNP Paribas Financial Markets's largest Q3 2018 buy was iShares Russell 2000 Value ETF: 504,000 shares worth $67M.
  • BNP Paribas Financial Markets added most to Apple in Q3 2018, an estimated $414M increase.
  • BNP Paribas Financial Markets's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $261M.
  • BNP Paribas Financial Markets fully exited Cavium, Inc. in Q3 2018, selling an estimated $28.7M.
  • BNP Paribas Financial Markets's ten largest holdings make up 20% of its $67.7B portfolio in Q3 2018.
  • BNP Paribas Financial Markets opened 154 new positions and closed 132 in Q3 2018.
  • BNP Paribas Financial Markets's portfolio value rose 13% quarter-over-quarter to $67.7B.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2018, filed 7 Nov 2018.